JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Brien, L. M.
Right arrow Articles by Fay, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Brien, L. M.
Right arrow Articles by Fay, P. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 45, Issue of November 10, 1995 pp. 27087-27092
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Localization of Factor IXa and Factor VIIIa Interactive Sites

(Received for publication, August 25, 1995)

Lynn M. O'Brien Leonid V. Medved Philip J. Fay

The contribution of the catalytic and noncatalytic domains of factor IXa to the interaction with its cofactor, factor VIIIa, was evaluated. Two proteolytic fragments of factor IXa, lacking some or all of the serine protease domain, failed to mimic the ability of factor IXa to enhance the reconstitution of factor VIIIa from isolated A1/A3-C1-C2 dimer and A2 subunit. Both fragments, however, inhibited this factor IXa-dependent activity. Selective thermal denaturation of the factor IXa serine protease domain eliminated its effect on factor VIIIa reconstitution. Modification of factor IXa with dansyl-Glu-Gly-Arg chloromethyl ketone (DEGR-IXa) stabilized this domain, and heat-treated DEGR-IXa retained its ability to enhance factor VIIIa reconstitution. These results indicate the importance of the serine protease domain as well as structures residing in the factor IXa light chain (-carboxyglutamic acid and/or epidermal growth factor domains) for cofactor stabilizing activity. In the presence of phospholipid, the A1/A3-C1-C2 dimer produced a saturable increase in the fluorescence anisotropy of fluorescein-Phe-Phe-Arg chloromethyl ketone-modified factor IXa (Fl-FFR-IXa). This effect was inhibited by a factor IXa fragment comprised of the -carboxyglutamic acid and epidermal growth factor domains. The difference in Fl-FFR-IXa anisotropy in the presence of A1/A3-C1-C2 dimer (Deltar = 0.043) compared with factor VIIIa (Deltar = 0.069) represented the contribution of the A2 subunit. A peptide corresponding to factor VIII A2 domain residues 558-565 decreased the factor VIIIa dependent-anisotropy of Fl-FFR-IXa to a value similar to that observed with the A1/A3-C1-C2 dimer. These results support a model of multiple interactive sites in the association of the enzyme-cofactor complex and localize sites for the A1/A3-C1-C2 dimer and the A2 subunit to the factor IXa light chain and serine protease domain, respectively.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Yang, Y.-J. Chang, S.-W. Lin, and P. N. Walsh
Identification of Residues Asn89, Ile90, and Val107 of the Factor IXa Second Epidermal Growth Factor Domain That Are Essential for the Assembly of the Factor X-activating Complex on Activated Platelets
J. Biol. Chem., November 5, 2004; 279(45): 46400 - 46405.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Blostein, B. C. Furie, I. Rajotte, and B. Furie
The Gla Domain of Factor IXa Binds to Factor VIIIa in the Tenase Complex
J. Biol. Chem., August 15, 2003; 278(33): 31297 - 31302.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Steen, B. O. Villoutreix, E. A. Norstrom, T. Yamazaki, and B. Dahlback
Defining the Factor Xa-binding Site on Factor Va by Site-directed Glycosylation
J. Biol. Chem., December 13, 2002; 277(51): 50022 - 50029.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. V. Jenkins, J. Freas, K. M. Schmidt, Q. Zhou, and P. J. Fay
Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex
Blood, June 28, 2002; 100(2): 501 - 508.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. H. N. Celie, G. van Stempvoort, C. Fribourg, L. J. Schurgers, P. J. Lenting, and K. Mertens
The Connecting Segment between Both Epidermal Growth Factor-like Domains in Blood Coagulation Factor IX Contributes to Stimulation by Factor VIIIa and Its Isolated A2 Domain
J. Biol. Chem., May 31, 2002; 277(23): 20214 - 20220.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. K. Rosenblum, K. Schmidt, J. Freas, M. Mastri, and P. J. Fay
Cofactor Activities of Factor VIIIa and A2 Subunit following Cleavage of A1 Subunit at Arg336
J. Biol. Chem., March 29, 2002; 277(14): 11664 - 11669.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. D. Christophe, P. J. Lenting, G. Cherel, M. Boon-Spijker, J.-M. Lavergne, R. Boertjes, M.-E. Briquel, A. de Goede-Bolder, J. Goudemand, S. Gaillard, et al.
Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B
Blood, September 1, 2001; 98(5): 1416 - 1423.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S. Stoylova, P. J. Lenting, G. Kemball-Cook, and A. Holzenburg
Electron Crystallography of Human Blood Coagulation Factor VIII Bound to Phospholipid Monolayers
J. Biol. Chem., December 17, 1999; 274(51): 36573 - 36578.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Fay and D. Scandella
Human Inhibitor Antibodies Specific for the Factor VIII A2 Domain Disrupt the Interaction between the Subunit and Factor IXa
J. Biol. Chem., October 15, 1999; 274(42): 29826 - 29830.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Mathur and S. P. Bajaj
Protease and EGF1 Domains of Factor IXa Play Distinct Roles in Binding to Factor VIIIa. IMPORTANCE OF HELIX 330 (HELIX 162 IN CHYMOTRYPSIN) OF PROTEASE DOMAIN OF FACTOR IXa IN ITS INTERACTION WITH FACTOR VIIIa
J. Biol. Chem., June 25, 1999; 274(26): 18477 - 18486.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Fay, K. Koshibu, and M. Mastri
The A1 and A2 Subunits of Factor VIIIa Synergistically Stimulate Factor IXa Catalytic Activity
J. Biol. Chem., May 28, 1999; 274(22): 15401 - 15406.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S.W. Pipe, A.N. Eickhorst, S.H. McKinley, E.L. Saenko, and R.J. Kaufman
Mild Hemophilia A Caused by Increased Rate of Factor VIII A2 Subunit Dissociation: Evidence for Nonproteolytic Inactivation of Factor VIIIa In Vivo
Blood, January 1, 1999; 93(1): 176 - 183.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. J. Lenting, J. A. van Mourik, and K. Mertens
The Life Cycle of Coagulation Factor VIII in View of Its Structure and Function
Blood, December 1, 1998; 92(11): 3983 - 3996.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Fay and K. Koshibu
The A2 Subunit of Factor VIIIa Modulates the Active Site of Factor IXa
J. Biol. Chem., July 24, 1998; 273(30): 19049 - 19054.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Zhong, E. L. Saenko, M. Shima, M. Felch, and D. Scandella
Some Human Inhibitor Antibodies Interfere With Factor VIII Binding to Factor IX
Blood, July 1, 1998; 92(1): 136 - 142.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Amano, R. Sarkar, S. Pemberton, G. Kemball-Cook, H. H. Kazazian Jr, and R. J. Kaufman
The Molecular Basis for Cross-Reacting Material-Positive Hemophilia A Due to Missense Mutations Within the A2-Domain of Factor VIII
Blood, January 15, 1998; 91(2): 538 - 548.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. M. O'Brien, C. F. Huggins, and P. J. Fay
Interacting Regions in the A1 and A2 Subunits of Factor VIIIa Identified by Zero-Length Cross-Linking
Blood, November 15, 1997; 90(10): 3943 - 3950.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. W. Pipe and R. J. Kaufman
Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa
PNAS, October 28, 1997; 94(22): 11851 - 11856.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Mathur, D. Zhong, A. K. Sabharwal, K. J. Smith, and S. P. Bajaj
Interaction of Factor IXa with Factor VIIIa. EFFECTS OF PROTEASE DOMAIN Ca2+ BINDING SITE, PROTEOLYSIS IN THE AUTOLYSIS LOOP, PHOSPHOLIPID, AND FACTOR X
J. Biol. Chem., September 12, 1997; 272(37): 23418 - 23426.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Pemberton, P. Lindley, V. Zaitsev, G. Card, E.G.D. Tuddenham, and G. Kemball-Cook
A Molecular Model for the Triplicated A Domains of Human Factor VIII Based on the Crystal Structure of Human Ceruloplasmin
Blood, April 1, 1997; 89(7): 2413 - 2421.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Fay, T. L. Beattie, L. M. Regan, L. M. O'Brien, and R. J. Kaufman
Model for the Factor VIIIa-dependent Decay of the Intrinsic Factor Xase
J. Biol. Chem., March 15, 1996; 271(11): 6027 - 6032.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. M. Regan, L. M. O'Brien, T. L. Beattie, K. Sudhakar, F. J. Walker, and P. J. Fay
Activated Protein C-catalyzed Proteolysis of Factor VIIIa Alters Its Interactions within Factor Xase
J. Biol. Chem., February 23, 1996; 271(8): 3982 - 3987.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.